Press Releases
Company News
View Summary Medivation Voted Top Workplace in San Francisco Bay Area for Fourth Year in a Row
Jun 27, 2016
PDF 9.8 KB Add to Briefcase
View Summary Glass Lewis Recommends Medivation's Stockholders Support the Company's Current Board
Jun 24, 2016
PDF 19.9 KB Add to Briefcase
View Summary Medivation Sends Letter to Stockholders to Set the Record Straight on Sanofi's Misleading Claims
Jun 23, 2016
PDF 18.2 KB Add to Briefcase
View Summary Medivation's Pidilizumab Shows Potential Clinical Benefit and Safety in Children With Diffuse Intrinsic Pontine Glioma (DIPG)
Jun 16, 2016
PDF 13.2 KB Add to Briefcase
View Summary Medivation Files Definitive Consent Revocation Statement and Mails Letter to Stockholders
Jun 13, 2016
PDF 82.1 KB Add to Briefcase
View Summary Medivation and Astellas Initiate Phase III Trial of Enzalutamide in Patients With Triple-Negative Breast Cancer
Jun 2, 2016
PDF 75.3 KB Add to Briefcase
View Summary Medivation Sets Record Date for Sanofi's Proposed Consent Solicitation
Jun 1, 2016
PDF 15.1 KB Add to Briefcase
View Summary Medivation Files Preliminary Consent Revocation Statement
May 27, 2016
PDF 24.6 KB Add to Briefcase
View Summary Medivation to Present at the Following Conferences
May 25, 2016
PDF 11.5 KB Add to Briefcase
View Summary Medivation Urges Stockholders to Reject Sanofi's Attempt to Replace Medivation Board of Directors
May 25, 2016
PDF 16.5 KB Add to Briefcase
View Summary Arm of I-SPY 2 TRIAL Investigating Medivation's Talazoparib for Treatment of Breast Cancer Activated
May 23, 2016
PDF 53.0 KB Add to Briefcase
View Summary Medivation Receives Prestigious Award From American Urological Association (AUA)
May 11, 2016
PDF 10.3 KB Add to Briefcase
View Summary Medivation Reports First Quarter 2016 Financial Results
May 5, 2016
PDF 100.5 KB Add to Briefcase
View Summary Medivation Reiterates Rejection of Sanofi's Substantially Inadequate Proposal
May 5, 2016
PDF 18.1 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2016 Financial Results Teleconference on May 5, 2016
May 3, 2016
PDF 11.3 KB Add to Briefcase
View Summary Medivation's Board of Directors Unanimously Rejects Sanofi's Unsolicited Proposal
Apr 29, 2016
PDF 23.1 KB Add to Briefcase
View Summary Medivation Confirms Receipt of Unsolicited Proposal From Sanofi
Apr 28, 2016
PDF 11.0 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conferences
Apr 27, 2016
PDF 11.2 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2016 Financial Results Teleconference on May 5, 2016
Apr 21, 2016
PDF 9.0 KB Add to Briefcase
View Summary Medivation Announces Presentation of Phase 2 Enzalutamide Data Evaluating Potential Immune-Activating Properties in Non-Metastatic Castration Sensitive Prostate Cancer Patients
Apr 20, 2016
PDF 69.7 KB Add to Briefcase
Showing 1-20 of 380 Page: 1 2 3 4 5 ... 19  Next 20
Add to Briefcase = add release to Briefcase

Top